- Endo Settles New York State Opioid Cases and Provides Update on Remaining Opioid Litigation
- Endo Comments on Non-Infringement Ruling in VASOSTRICT® Patent Litigation
- Endo Reports Second-Quarter 2021 Financial Results And Updates 2021 Financial Guidance
- Endo Announces Execution of Definitive Settlement Agreement and Release Resolving Tennessee State Court Case
- Endo Presents New Investigational Collagenase Clostridium Histolyticum Data at the American Podiatric Medical Association Annual Scientific Meeting
- Endo Announces Agreement in Principle to Settle Tennessee State Court Case
- Endo Comments on Tennessee Appeals Court Orders
- Endo to Announce Second Quarter 2021 Financial Results
- Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at Cosmetic Bootcamp 2021
As of last trade
Endo International PLC (EO7:BRN) traded at 6.22, 0.00% below its 52-week high of 6.22, set on Jan 04, 2021.
6.22Jan 04 20216.22Jan 04 2021
Markit short selling activity
|Market cap||644.46m USD|
|EPS (TTM)||-0.0966 |
Data delayed at least 15 minutes, as of Jan 04 2021.